Overcoming Barriers of Acetylcholinesterase Inhibitors for Alzheimer’s Disease

3/11/2019 16:45 - 17:20

  • Reasons for the continued success of Acetylcholinesterase inhibitors as NCE
  • Most common issues with solubility and low bioavailability
  • Crossing the Blood Brain Barrier